Delivery Order SPE2DB24D2106-SPE2DB25FAWBU
Award Date 8/20/25
Potential Completion Date 8/21/25
Potential Value $3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pods valued at $1,222.32. This competitive, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical...
- The Defense Logistics Agency awarded a $23,235.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. Issued on July 26, 2025, with an ultimate completion date of July 28, 2025, this delivery order represents a competitively awarded, non-set-aside contract with performance located at the contractor's corporate office in Conshohocken, Pennsylvania. The OmniPod 5 system is an integrated insulin pump and continuous glucose...
- The Defense Logistics Agency awarded a delivery order valued at $84,729.11 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pump pods on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a Delivery Order valued at $13,959.71 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price, non-set-aside contract is performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents medical supplies supporting the federal government's healthcare procurement needs, specifically insulin...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for OmniPod 5 Dexcom G7 generation 5 insulin infusion pump pods. This $32,078.67 firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a competitive award with no set-aside designation. The products will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $2,240.92 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. This competitive award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price transaction with no set-aside designation. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.30 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pods. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 4, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting federal medical supply chain requirements. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $9,989.48 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods on July 25, 2025, with a completion date of July 28, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to the vendor based in Conshohocken, Pennsylvania. This delivery order represents a relatively small-value transaction within the broader federal medical procurement landscape and will be...
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $9,090.51 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pump pods on August 21, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the vendor's demonstrated capability to compete...